Merck, the second-biggest US drugmaker, agreed to buy Idenix Pharmaceuticals for about $3.85 billion. Photo: Bloomberg

Merck, the second-biggest US drugmaker, agreed to buy Idenix Pharmaceuticals for about $3.85 billion to expand its experimental pipeline for hepatiti(...)

A worker  outside a Merck facility in  New Jersey, US, yesterday.  The  drugmaker  will eliminate  8,500 of its 81,000 global workforce  in its latest revamp. Photograph: Emile Wamsteker/Bloomberg

Merck, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, has said it plans to cut annual operating costs by(...)

MSD Ireland (Merck Sharp & Dohme) chief executive Brian Longstreet photographed at the company’s hq in Dublin

A review panel this week decided that a revolutionary new treatment for insomnia should be approved for use – but only at the lower of two dose(...)